EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

ELANTAS Beck India Limited (500123) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of ELANTAS Beck India Limited ₹4,665, price ₹13,442, upside -65.3%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Basic Materials · IN

EB Some data Sep 24, 2026

ELANTAS Beck India Limited

500123 · BSE

Stretched ValuationQuality growthStrong overvaluation with only moderate quality.

!Fair value ₹4,665 · Strongly overvalued (−65.3%)
✓Quality 64/100
✓Healthy Growth (revenue 5y +17.2 %/yr)
✓Solidly profitable · 13.9% net margin (TTM)
✓generates free cash flow
✓0.2% dividend yield · Well covered
!Mixed vs. peers (5/9)
!Moderate moat 63/100
!Evidence only medium, so the estimate is less certain
!Weak on dividend: 4 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹14,744 ₹3,231 Fair Value ₹4,665 Apr 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range ₹3,231 – ₹14,744 · fair‑value band ₹2,908 – ₹6,829 · the ₹13,442 price screens above the ₹4,665 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow ELANTAS Beck India in your weekly email

Every Wednesday you see whether ELANTAS Beck India is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

ELANTAS Beck India Limited manufactures and sells a range of specialty chemicals for the electrical insulation and construction industries primarily in India. It operates through two segments, Electrical Insulations; and Engineering & Electronic Resins and Materials.

Show more

ELANTAS Beck India Limited manufactures and sells a range of specialty chemicals for the electrical insulation and construction industries primarily in India. It operates through two segments, Electrical Insulations; and Engineering & Electronic Resins and Materials. The company offers electrical insulation systems products, including wire enamels, electrical insulating varnishes and resins, flexible electrical insulation products, and casting and potting compounds; and electronics products, such as potting compounds and thermal interface materials. It also provides engineering materials comprising a range of resinous construction chemicals for industrial floorings, protective coatings, structural repairs, waterproofing, adhesives, and sealants for various market segments, such as pharmaceuticals, food, electronics, engineering, construction, and hydraulic structures. In addition, the company offers polyamide hardeners for epoxy systems used in conjunction with epoxy resins to produce top coats and primers, as well as thermosetting adhesives for various substrates. The company was incorporated in 1956 and is based in Pune, India. ELANTAS Beck India Limited is a subsidiary of ELANTAS GmbH.

Stock analysis

ELANTAS Beck India Limited (500123) currently trades at ₹13,442, while our model-based Fair Value estimate is ₹4,665, 65.3% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹2,954 per share, and 0 of the 26 models we run sit above the ₹13,442 price.

Bear case: the Asset-Based group reads lowest at ₹852.08, and 26 of the 26 models stay below the price. Evidence for this calculation is medium.

Scenario range: ₹2,908 (bear) to ₹6,829 (bull), the price of ₹13,442 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 64/100 (solid quality), in the Basic Materials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

ELANTAS Beck India Limited reported revenue of ₹8.5B in FY2025 versus ₹5.2B in FY2021, a compound +12.9%/yr. Reported net income was ₹1.5B in FY2025, compounding +21.9%/yr from FY2021.

Key figures

Market cap ₹18.7B (≈ $194M) · P/E ratio 38.7 · P/S ratio 6.74 · EPS (TTM) ₹62.79 · Dividend yield 0.2% · Net margin 17.4% · Return on assets (EBIT) 12.9% · Operating margin 12.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (medium confidence).

What moves the price

The share trades about 9% below its 52-week high and 81% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −65%, 500123 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (₹82.99 to ₹5,402). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ₹2,908 Fair Value ₹4,665 Bull ₹6,829
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (₹43.70 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF ₹1,187 ₹1,782 ₹2,608 78
Growth DCF ₹1,172 ₹1,694 ₹2,372 76
Residual Income ₹1,139 ₹1,319 ₹1,834 76
All 26 models by family
DCF Models
FCF DCF ₹1,187 ₹1,782 ₹2,608 78
Owner Earnings ₹1,666 ₹2,518 ₹3,702 73
5Y Revenue Exit ₹1,173 ₹1,887 ₹2,832 69
5Y EBITDA Exit ₹1,397 ₹2,337 ₹3,490 71
5Y P/E Exit ₹1,790 ₹3,128 ₹4,629 67
10Y Revenue Exit ₹1,134 ₹1,743 ₹2,628 64
10Y EBITDA Exit ₹1,287 ₹2,021 ₹3,087 65
10Y P/E Exit ₹1,508 ₹2,509 ₹3,882 60
Earnings-Based
Graham-Dodd ₹1,268 ₹5,402 ₹7,378 64
Lynch FV ₹1,379 ₹1,970 ₹2,561 61
PEG = 1.0 ₹1,379 ₹1,970 ₹2,561 57
EPV ₹1,307 ₹1,454 ₹1,573 70
Dividend Discount
Gordon GGM ₹52.24 ₹87.50 ₹113.57 68
DDM Multi-Stage ₹52.24 ₹82.99 ₹94.14 67
Multiples
P/E Multiple ₹2,377 ₹3,169 ₹3,961 63
P/S Multiple ₹1,203 ₹1,604 ₹2,005 58
P/B Multiple ₹2,377 ₹3,169 ₹3,961 55
EV/EBIT ₹2,082 ₹2,748 ₹3,415 63
EV/EBITDA ₹1,712 ₹2,255 ₹2,798 64
EV/Revenue ₹1,206 ₹1,687 ₹2,169 51
Asset-Based
NCAV (Graham) ₹635.88 ₹852.08 ₹1,272 51
Growth DCF
Growth DCF ₹1,172 ₹1,694 ₹2,372 76
Rev-Margin DCF ₹1,173 ₹1,879 ₹2,767 69
Economic Profit
Residual Income ₹1,139 ₹1,319 ₹1,834 76
ROIC Compounder ₹1,319 ₹1,568 ₹1,872 70
Growth Earnings
Growth-Adj P/E ₹2,068 ₹2,954 ₹3,840 67

Open the full fair value analysis →

Notify me when 500123 reaches fair value

Put 500123 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 64/100

Of which business quality 64 · Market factors (momentum, volatility) 75

Profitability 61
Margins and returns on capital today
Quality Growth 59
Are margins and returns improving?
Cashflow 51
Earnings quality: real cash, not paper profit
Fin. Strength 84
Balance sheet, leverage, solvency risk
Investment 36
Disciplined investing over empire-building
Low Volatility 73
Calm price path (market factor)
Momentum 78
Price trend over the last 3–12 months (market factor)
52W Momentum 70
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+13.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.2%
Start year 2020 (pandemic). Over 10 years: +9.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+19.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+19.1%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.19.1% vs 10.5%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 18%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+54.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +48.4% a year for the price.

500123 screens overvalued: fair value 65% below the price. Compare with Linde plc →

Compare ELANTAS Beck India Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 691 stocks

Beats the industry median on 5/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 64 · Top 25%
Fair Value upside −68.8% · Bottom 25%
Profitability
Return on assets 6.9% · Top 25%
Net margin (TTM) 13.9% · Top 25%
Operating margin (TTM) 12.6% · Above median
Growth and dividend
Revenue growth 19.4% · Above median
Dividend yield (TTM) 0.2% · Bottom 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (TTM) 38.7× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)97 · sector 59
PAST (return on equity)0 · sector 26
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)4 · sector 29

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $474.65 $441.72 −7%
The Sherwin-Williams Company SHW $330.44 $151.68 −54%
Ecolab Inc ECL $274.58 $96.56 −65%
Air Products and Chemicals, Inc APD $279.19 $121.30 −57%
Nan Ya Plastics Corporation 1303 238.00 TWD 234.23 TWD −2%
Givaudan SA GIVN CHF 3,360 CHF 1,527 −55%
Wanhua Chemical Group 600309 ¥69.45 ¥68.03 −2%
DSM-Firmenich AG DSFIR CHF 92.30 CHF 29.70 −68%
Asian Paints Limited ASIANPAINT ₹2,444 ₹1,479 −39%
PPG Industries, Inc PPG $104.67 $76.98 −26%

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "ELANTAS Beck India Limited Fair Value". https://www.fairvalue-calculator.com/stock/500123

Frequently asked questions

Is ELANTAS Beck India Limited (500123) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹4,665 versus a price of ₹13,442, about −65% upside (overvalued).
What is the fair value of 500123?
Our model-based fair value for ELANTAS Beck India Limited is ₹4,665 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹13,442.
What is the quality score of 500123?
ELANTAS Beck India Limited has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ELANTAS Beck India Limited (500123)?
Our model-based price target is the fair value of ₹4,665 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario ₹2,908, optimistic scenario ₹6,829. It is a calculation from audited fundamentals, not an analyst target.
What is the ELANTAS Beck India Limited stock forecast for 2026?
Our models put fair value at ₹4,665, about −65% upside versus a price of ₹13,442 (overvalued). Cautious scenario ₹2,908, optimistic scenario ₹6,829. The calculation is refreshed regularly with new filings.
What is the revenue of ELANTAS Beck India Limited (500123)?
ELANTAS Beck India Limited reported trailing-twelve-month revenue of about ₹3.6B (latest available figure, as of Sep 24, 2026).
Does ELANTAS Beck India Limited pay a dividend?
ELANTAS Beck India Limited currently shows a dividend yield of about 0.21% relative to its recent price (as of Sep 24, 2026).
What growth is priced into ELANTAS Beck India Limited (500123)?
For today's price to be fair in a discounted-cash-flow model, ELANTAS Beck India Limited would have to grow free cash flow by +54.5 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +17.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 500123 use?
Our models discount ELANTAS Beck India Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.37, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For ELANTAS Beck India Limited that is +54.5 % per year a year over ten years, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has ELANTAS Beck India Limited (500123) delivered so far?
Over the past 5 years revenue at ELANTAS Beck India Limited grew +17.2 % a year. The price currently implies +54.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of ELANTAS Beck India Limited (500123) growing?
The median revenue growth in the sector is +8.1 % a year. That is the yardstick for the growth priced into ELANTAS Beck India Limited (+54.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of ELANTAS Beck India Limited (500123)?
The free-cash-flow yield on the price is 0.90 %: that much free cash flow ELANTAS Beck India Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of ELANTAS Beck India Limited (500123)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ELANTAS Beck India Limited it is ₹4,665 per share (as of Sep 24, 2026), against a price of ₹13,442. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is ELANTAS Beck India Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 500123 trades above its calculated fair value: price ₹13,442, fair value ₹4,665, a gap of about −65% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 500123?
No. The price is what the market pays today (₹13,442); the fair value is what the company's own numbers justify (₹4,665). For ELANTAS Beck India Limited the two are ₹8,777 per share apart. That gap is exactly why we show both numbers side by side.
How much is ELANTAS Beck India Limited worth?
The market values ELANTAS Beck India Limited at about ₹18.7B (market capitalisation, as of Sep 24, 2026). Per share that is ₹13,442; our models calculate a fair value of ₹4,665 per share.
What do the bullish and bearish scenarios say about 500123?
Our models span a range for ELANTAS Beck India Limited: cautious scenario ₹2,908, base ₹4,665, optimistic ₹6,829 per share (as of Sep 24, 2026, price ₹13,442). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 500123?
ELANTAS Beck India Limited trades at a price-to-earnings ratio of 38.7 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹4,665 is built from several models across several years.
How far is 500123 from its 52-week high?
ELANTAS Beck India Limited trades at ₹13,442, about 9% below its 52-week high of ₹14,744 and 81% above the low of ₹7,408 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹4,665 is for.
Which stocks are comparable to ELANTAS Beck India Limited?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ELANTAS Beck India Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹13,442, calculated fair value ₹4,665 (−65%), Quality Score 64/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 500123 calculated?
We run ELANTAS Beck India Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹4,665, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. ELANTAS Beck India Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ELANTAS Beck India Limited (500123)?
The closing price on Oct 1, 2026 was ₹13,442. Our model-based fair value is ₹4,665, about −65% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ELANTAS Beck India Limited right now?
The price sits above even our optimistic bull case (₹6,829). The favourable scenario is already priced in. Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹2,908 to ₹6,829) leaves room in how you read the outcome.

Key figures of ELANTAS Beck India Limited

How large is the market capitalisation of ELANTAS Beck India Limited (500123)?
The market capitalisation of ELANTAS Beck India Limited is ₹18.7B (≈ $194M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ELANTAS Beck India Limited (500123)?
The price-to-sales ratio of ELANTAS Beck India Limited is 6.74 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of ELANTAS Beck India Limited (500123)?
Earnings per share at ELANTAS Beck India Limited are ₹62.79 (price ÷ EPS = P/E 38.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of ELANTAS Beck India Limited (500123)?
The dividend yield of ELANTAS Beck India Limited is 0.2% (payout 45.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of ELANTAS Beck India Limited (500123)?
The net margin of ELANTAS Beck India Limited is 17.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of ELANTAS Beck India Limited (500123)?
On an EBIT basis the return on assets of ELANTAS Beck India Limited is 12.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ELANTAS Beck India Limited (500123)?
The operating margin of ELANTAS Beck India Limited is 12.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ELANTAS Beck India Limited (500123)?
Revenue at ELANTAS Beck India Limited is growing +19.4% versus a year earlier (3y avg +9.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at ELANTAS Beck India Limited (500123)?
Earnings per share at ELANTAS Beck India Limited are growing +48.6% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch ELANTAS Beck India Limited in the live analysis

One click puts ELANTAS Beck India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.